Danske Bank A S lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 178,056 shares of the company’s stock after selling 12,200 shares during the period. Danske Bank A S’s holdings in GE HealthCare Technologies were worth $11,640,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Wellington Grp LLC lifted its holdings in shares of GE HealthCare Technologies by 68.9% in the 3rd quarter. Wellington Grp LLC now owns 19,890 shares of the company’s stock valued at $1,300,000 after buying an additional 8,115 shares during the period. Aberdeen Group plc grew its holdings in GE HealthCare Technologies by 247.4% during the third quarter. Aberdeen Group plc now owns 556,124 shares of the company’s stock worth $36,354,000 after acquiring an additional 396,044 shares during the period. Allworth Financial LP raised its position in GE HealthCare Technologies by 4.4% during the third quarter. Allworth Financial LP now owns 26,851 shares of the company’s stock valued at $1,719,000 after acquiring an additional 1,137 shares in the last quarter. Letko Brosseau & Associates Inc. raised its position in GE HealthCare Technologies by 0.6% during the third quarter. Letko Brosseau & Associates Inc. now owns 884,005 shares of the company’s stock valued at $57,787,000 after acquiring an additional 5,430 shares in the last quarter. Finally, Ritholtz Wealth Management acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $1,285,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of brokerages have recently commented on GEHC. UBS Group raised their price objective on shares of GE HealthCare Technologies from $73.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 3rd. Wolfe Research started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, October 20th. They issued a “peer perform” rating for the company. JPMorgan Chase & Co. increased their price target on shares of GE HealthCare Technologies from $70.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, October 29th. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Finally, Citigroup upped their price objective on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the stock a “neutral” rating in a research report on Thursday, October 29th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $82.17.
Get Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Trading Down 1.4%
Shares of GE HealthCare Technologies stock opened at $81.84 on Wednesday. The firm has a market capitalization of $37.00 billion, a PE ratio of 17.27, a P/E/G ratio of 2.09 and a beta of 0.65. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The firm’s 50-day moving average price is $71.13 and its 200 day moving average price is $70.15. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm had revenue of $5.51 billion during the quarter, compared to analysts’ expectations of $5.35 billion. During the same period in the previous year, the business earned $1.07 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.
GE HealthCare Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date was Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.38%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
See Also
- Five stocks we like better than GE HealthCare Technologies
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
